(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abiraterone, AstraZeneca, Cancer, chemotherapy, Eastern Cooperative Oncology Group, EcoG, hormones, HRR, IDMC, Independent Data Monitoring Committee, Lynparza, mCRPC, MSD, MSD Research Laboratories, Olaparib, PARP, PROpel Phase III, prostate cancer, Roy Baynes, rPFS, Susan Galbraith
New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the ability to swallow Evrysdi has demonstrated consistent clinically meaningful efficacy in adults, children, and babies two months and older and is now approved in 58 countries worldwide Further … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged DMD, Duchenne muscular dystrophy, Endeavor, Evrysdi, gene therapy, Hammersmith Infant Neurological Examination, HINE-2, Levi Garraway, M.D. Ph.D, motor milestones, neuromuscular, RAINBOWFISH study, risdiplam, Roche, Sarepta, SMA, spinal muscular atrophy, SRP-9001, World Muscle Society (WMS) Virtual Congress
(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original ‘red brick’ civic universities, has announced that its researchers are part of a new project to increase the number of care home staff that take … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Boots UK, Care England, care home staff, care homes, Day Lewis Pharmacy, Dr Alys Griffiths, Dr Amrish Patel, flu, flu vaccine, FluCare project, Liz Jones, National Care Forum, National Institute for Health Research, NIHR, pharmacists, Public Health England, researchers, UEA, University of East Anglia, University of Leicester, University of Liverpool, vaccine
Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy (PRESS RELEASE) PARIS, 8-Sep-2021 — /EuropaWire/ — Sanofi … Read the full press release
Posted in France, Healthcare, Investment, News, Pharma & Biotech
Tagged acquisition, anti-human thymocyte antibody preparation, anti-thymocyte globulin, belumosudil, biopharmaceutical company, cGVHD, chronic graft-versus-host disease, fibrotic diseases, General Medicines, Harlan Waksal M.D., hematopoietic stem cell mobilizer, immuno-oncology therapies, immunomodulating agent, immunosuppressive, Kadmon Holdings, Mozobil®, Olivier Charmeil, plerixafor, polyclonal, Rezurock™, Sanofi, systemic therapy, Thymoglobulin®, transformative therapies, transplant portfolio
(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release
(PRESS RELEASE) STOCKHOLM, 2-Sep-2021 — /EuropaWire/ — Investor AB (STO: INVE-B), a Swedish investment and holding company founded in 1916, has announced its support for the Agnafit Bidco¹’s bid for Sobi (Swedish Orphan Biovitrum AB). The company has undertaken to … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisitions, Advent International, Advent International Corporation, Agnafit Bidco, Aurora Investments Pte Ltd, Biovitrum, GIC Pte Ltd., GIC Special Investments Pte Ltd, Healthcare, hematology, hemophilia, immunology, Investor AB, Johan Forssell, public offer, shares, Sobi, Swedish Orphan Biovitrum AB, Swedish Orphan International
Seanactiv™ harnesses the power of fucus vesiculosus fucoidan to limit visible signs of aging and fatigue around the eyes New ingredient helps reduce the appearance of dark circles, crow’s feet wrinkles and under-eye dullness within just one week of application Three-step action … Read the full press release
(PRESS RELEASE) LONDON, 19-Aug-2021 — /EuropaWire/ — Savills (LON: SVS), one of the world’s leading property advisors, has released its latest research on the European office space market. According to the study there has been a shift in demand for … Read the full press release
(PRESS RELEASE) AMERSFOORT, 10-Aug-2021 — /EuropaWire/ — Nutreco, leading company in the field of animal nutrition and aquafeed, has announced it is leading a EUR 21 million financing round together with Aqua-Spark and PFR Life Science, a portfolio company of … Read the full press release
Posted in Agriculture, Artificial Intelligence (AI), Environment, Investment, Netherlands, News, Pharma & Biotech, Poland, Technology
Tagged Aeromonas, AHPND, AI, Amy Novogratz, Angel investors, antibiotics, Aqua-Spark, aquaculture, Avian Pathogenic E. Coli, bacteriophages, climate goals, environmental sustainability, farmers, GHG emission, investment, Jarosław Dastych, Laëtitia Gerbe, livestock farming, Mastitis, Matthew Tebeau, Mike Velings, Montis Capital, Nutreco, Paweł Borys, PFR, PFR Life Science, Polish Development Fund, protein production, Proteon Pharmaceuticals, Pseudomonas, Rob Koremans, Salmonella, Seventure Partners, Skretting, soil pollution, sustainability, water pollution, Wojciech Szwankowski
(PRESS RELEASE) VALBY, 4-Aug-2021 — /EuropaWire/ — Lundbeck (CPH: LUN), a Danish international pharmaceutical company, has announced it will partner with Rgenta Therapeutics, Cambridge, MA-based developer of oral, small-molecule RNA-targeting medicines with an initial focus on oncology, to discover small … Read the full press release
Posted in Denmark, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged disease-causing genes, Klaus Bæk Simonsen, Lundbeck, neuroscience, Rgenta Therapeutics, RNA pathways, RNA regulation, Simon Xi, small molecule RNA modulators, small molecules, Tarek Samad, treatments for brain diseases
Application is being reviewed under the US FDA’s Real-Time Oncology Review pilot programme Based on results of the Phase III IMpower010 study, presented at ASCO, that showed adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive early-stage lung cancer, compared with … Read the full press release
Posted in Healthcare, Marketing, News, Pharma & Biotech, Switzerland
Tagged atezolizumab, Cancer Immunotherapy, chemotherapy, FDA, Levi Garraway, lung cancer, non-small cell lung cancer, NSCLC, Real-Time Oncology Review, Roche, sBLA, supplemental Biologics License Application, Tecentriq®, treatment, tumours
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in 2015 pays off Evonik aims to more than double the share of system solutions in Nutrition & Care by 2030 … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, Investment, News, Pharma & Biotech, Technology
Tagged acquisition, Bernhard Mohr, biomaterials, bioresorbable polymers, biotech company, biotechnologically derived cellulose, burn treatment, Dana Kralisch, Dermatology, epicite, Evonik, Friedrich-Schiller-University, hydroactive skin care, implantable medical devices, JeNaCell, medical device technologies, medical technology, medical wound dressing, microclimate, pharmaceutical drug products, RESOMER®, surgical wounds, Thomas Riermeier, treatment of chronic wounds, treatment of wounds and burns
(PRESS RELEASE) BERLIN, 26-Jul-2021 — /EuropaWire/ — Bayer, a global enterprise with core competencies in the life science fields of health care and nutrition, has announced that Prof. Dr. Dominik Ruettinger has been appointed as the new Head of Research … Read the full press release
Posted in Germany, Healthcare, Management, News, Pharma & Biotech, Technology
Tagged Amgen Inc., Bayer AG, Biomarker Development, Blinatumumab, Blincyto, Dominik Ruettinger, Dr. Christian Rommel, Early Clinical, Micromet Inc., oncology, pharmaceuticals, pRED, Prof. Dr. Dominik Ruettinger, RESEARCH, Roche, Surgical Oncology, therapeutic development, translational clinical research, tumor, tumor immunology, University of Munich
(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world’s leading logistics companies, has announced that its subsidiary QuickSTAT has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s … Read the full press release
Posted in Business, Healthcare, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Switzerland, Transportation & Logistics
Tagged biologics, biomedical science hub, cell therapy, clinical research samples, clinical trial logistics, clinical trial supplies, conditioning facility, control tower, Cyril Leger, gene therapy, Healthcare, Healthcare Logistics, investigational drugs, investment, Jack Liu, Kuehne+Nagel, logistics, pharma, pharmaceutical product lifecycle, QuickSTAT, Singapore, time and temperature shipping, vaccines
(PRESS RELEASE) PARIS, 20-Jul-2021 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced fexinidazole approval by the US Food and Drug Administration (FDA) as the first all-oral treatment for both stages of the … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech
Tagged Central African Republic, Democratic Republic of Congo, DNDi, Dr Bernard Pécoul, Drugs for Neglected Diseases initiative, FDA, fexinidazole, HAT, Human African trypanosomiasis, Luc Kuykens, National Sleeping Sickness Programs, neuropsychiatric symptoms, parasitic disease, Sanofi, sleeping sickness, Trypanosoma brucei gambiense, tse-tse fly, US Food and Drug Administration, WHO, World Health Organization
Innovation Center project of Merck aims to develop smart neurostimulators for targeted treatment of chronic diseases Second collaboration within the Bioelectronics innovation field of Merck focuses on increasing the selectivity and power efficiency of the device to enable energy intensive … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged bioelectronic, bioelectronic therapies, bioelectronics, Bioelectronics innovation, Carolina Aguilar, chronic diseases, electronic therapies, endocrine disorders, graphene, graphene electrodes, graphene interfaces, Inbrain Neuroelectronics, inflammatory disorders, Innervia Bioelectronics, Jurriaan Baker, Laura Matz, Merck, metabolic disorders, neuroloop GmbH, neurostimulators, physiological datasets, precise signal coding, Reduced Graphene Oxide, rGO, Robert Spoelgen, selective neurostimulation, start-up, vagus nerve
(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science
Tagged American Cancer Association, B66, bioscience, Biotech, bladder, breast, Cancer, colorectal, Dr Eric Metzger, Freiburg, Germany, histone methyltransferase, inhibitors, KMT9, lung cancer, Manfred Jung, Mike Dunckley, pharma, Professor Manfred Jung, Professor Roland Schule, Professors Roland Schule, prostate cancer, prostate tumours, University of Freiburg
Important standards for the food and feed industry Quality, traceability and safety along the complete production chain (PRESS RELEASE) LUDWIGSHAFEN, 14-Jun-2021 — /EuropaWire/ — German multinational chemical company BASF announces that it has obtained GMP+ and ISO 22000 certifications for … Read the full press release
Posted in Apparel, Fashion & Beauty, Chemicals, Food & Beverage, Germany, Industrial, Management, News, Pharma & Biotech, Technology
Tagged Agustin Sanchez, BASF, certifications, crude glycerin production, Dusseldorf-Holthausen, feed industry, feed safety management system, FOOD, food safety, GMP+, ISO 22000, personal care, pharma, production chain, Quality, safety, traceability
(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release
Posted in Belgium, France, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged algoritme, ATTD 2021, ATTD2021, Bernhard Gehr, CEA-Leti, CERITD, DBLG1, DBLG1 AID-systeem, DBLG1 System, DBLG1 System met Accu-Check Insight, DBLG1-algoritme, Diabeloop, Diabetes, diabetes type 1, diabetesbehandeling, diabetologen, diabetoloog, Dr. Guillaume Charpentier, Erik Huneker, gepersonaliseerde behandeling, insulinedosis, m&i Fachklinik Bad Heilbrunn, Marc Julien, Nicole Wetzels, Roche Diabetes Care, T1D, Yousra Tourki, zelflerend algoritme
(PRESS RELEASE) SOPHIA ANTIPOLIS CEDEX, France, 12-Apr-2021 — /EuropaWire/ — EuroCMR 2021 will highlight how magnetic resonance imaging (MRI) of the heart helps physicians pinpoint diagnoses and tailor treatment. EuroCMR 2021 will take place on 6 to 8 May online. … Read the full press release
Posted in Artificial Intelligence (AI), Education, France, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged 3D printing, AI, artificial-intelligence, Cardiac Magnetic Resonance, cardiologists, cardiotoxicity, cardiovascular magnetic resonance congress, chemotherapy, claustrophobic patients, CMR, CMR conference, computed tomography, Computer scientists, congenital heart disease, coronary arteries, COVID-19, CT scans, EACVI, ENDS, engineers, ESC, EuroCMR, EuroCMR 2021, European Association of Cardiovascular Imaging, European Society of Cardiology, Heart, heart attack treatment, heart function, heart muscle, heart problems, hypnosis, ICD, imaging scientists, implantable cardioverter defibrillator, inherited heart conditions, ischaemic heart disease, lymphoma survivors, magnetic resonance imaging, MRI, MRI physicists, myocardial infarction, oedema, Professor Robert Manka, radiographers, Radiologists, stroke, sudden cardiac death
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?